These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 23091860

  • 1. [Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension].
    Martyniuk TV, Arkhipova OA, Kobal' EA, Danilov NM, Chazova IE.
    Ter Arkh; 2012; 84(9):83-8. PubMed ID: 23091860
    [Abstract] [Full Text] [Related]

  • 2. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E, Erturk M, Birant A, Kurtar Mansıroglu A, Akturk IF, Karakurt H, Yalcin AA, Uzun F, Somuncu MU, Yildirim A.
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [Abstract] [Full Text] [Related]

  • 3. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators.
    Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W.
    Circulation; 2000 Oct 31; 102(18):2222-7. PubMed ID: 11056096
    [Abstract] [Full Text] [Related]

  • 4. Duration of the haemodynamic action of a 24-h infusion of levosimendan in patients with congestive heart failure.
    Lilleberg J, Laine M, Palkama T, Kivikko M, Pohjanjousi P, Kupari M.
    Eur J Heart Fail; 2007 Jan 31; 9(1):75-82. PubMed ID: 16829185
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.
    Cardiovasc Ther; 2013 Apr 31; 31(2):108-14. PubMed ID: 23490237
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May 31; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 15. Levosimendan improves hemodynamic status in critically ill patients with severe aortic stenosis and left ventricular dysfunction: an interventional study.
    García-González MJ, Jorge-Pérez P, Jiménez-Sosa A, Acea AB, Lacalzada Almeida JB, Ferrer Hita JJ.
    Cardiovasc Ther; 2015 Aug 31; 33(4):193-9. PubMed ID: 25959786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Levosimendan and pulmonary hypertension.
    Cavusoglu Y, Beyaztas A, Birdane A, Ata N.
    J Cardiovasc Med (Hagerstown); 2010 Jul 31; 11(7):478-80. PubMed ID: 20516805
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
    Paksoy F, Ulaş T, Tursun I, Dal MS, Oztekin E, Borlu F.
    Anadolu Kardiyol Derg; 2012 Feb 31; 12(1):16-22. PubMed ID: 22214738
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.